Pt 141 vs Melanotan
Which Is Right for You? Complete Comparison (2026)
PT-141 vs Melanotan II — FDA-approved bremelanotide (selective MC4R for libido) vs non-selective Melanotan II (tanning, libido, appetite).
Pt 141 vs Melanotan: At a Glance
Pt 141
- ✓Melanocortin receptor agonist (MC3R/MC4R)
- ✓FDA-approved as Vyleesi for hypoactive sexual desire in women
- ✓Acts centrally in the hypothalamus to enhance sexual arousal
- ✓Derived from Melanotan II but with reduced tanning effect
- ✓Administered 45 minutes before anticipated sexual activity
Melanotan
- ✓Synthetic cyclic analogue of alpha-MSH
- ✓Stimulates melanogenesis — darkens skin without UV exposure
- ✓Non-selective melanocortin agonist (MC1R-MC5R)
- ✓Side effects include nausea, appetite suppression, and sexual arousal
- ✓Not approved by any regulatory agency — significant safety concerns
Detailed Comparison
| Feature | Pt 141 | Melanotan |
|---|---|---|
| Mechanism | Melanocortin receptor agonist | Synthetic melanocortin peptide |
| Dosing | 1.75 mg SC as needed (max 1 dose/24h, 8 doses/month) | 0.5-1 mg SC daily (loading) then weekly (anecdotal) |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Half-life | ~2.7 hours | ~2 hours |
| FDA Status | FDA-approved (Vyleesi) | Not approved — banned in multiple countries |
| Key Trial | Kingsberg SA et al. Obstet Gynecol 2019 — RECONNECT trial | Dorr RT et al. Life Sci 1996 — phase I clinical study |
| Side Effects | Nausea (40%), flushing, headache, injection site reactions | Nausea, flushing, mole darkening, priapism risk, potential melanoma concern |
Which Should You Choose?
PT-141 (Bremelanotide) (melanocortin receptor agonist) and Melanotan II (synthetic melanocortin peptide) serve different clinical roles despite both being in the Sexual health peptide space. PT-141 (Bremelanotide) synthetic melanocortin peptide that activates mc3r and mc4r receptors in the cns to enhance sexual desire. Melanotan II synthetic cyclic alpha-msh analogue that stimulates melanogenesis (skin darkening), reduces appetite, and enhances sexual arousal via melanocortin receptors.
Whichever you choose, track your protocol in Shotlee to build clean data for dose optimization and outcomes comparison.
Track Both in Shotlee
Shotlee supports tracking any medication or peptide. Compare your results across different protocols with clean dose logs and outcome data.
Making an Informed Choice Between Pt 141 and Melanotan
Choosing between Pt 141 and Melanotan depends on multiple individual factors including your specific health goals, tolerance profile, insurance coverage, and prescriber recommendation. While clinical trial data provides population-level efficacy and safety comparisons, your personal response may differ based on genetics, baseline health, concurrent conditions, and lifestyle factors. Use this comparison as a starting framework and discuss the specifics with your healthcare provider.
Head-to-head clinical trial data between Pt 141 and Melanotan is the gold standard for comparison, but such direct comparisons are not always available for every pair of compounds. Where head-to-head data is lacking, cross-trial comparisons provide useful but imperfect approximations — differences in patient populations, trial design, and endpoint definitions mean that numbers from separate trials are not directly interchangeable. Keep this context in mind when evaluating the comparison data presented here.
Tracking your personal response data in Shotlee is particularly valuable when switching between medications or considering a change. By documenting your outcomes on your current protocol — including efficacy metrics, side effect profile, adherence rate, and quality of life measures — you create an objective baseline for comparison if you transition to the alternative compound. This data transforms a subjective switching decision into an evidence-based protocol optimization.
Pt 141 vs Melanotan: Common Questions
PT-141 (Bremelanotide) is a melanocortin receptor agonist while Melanotan II is a synthetic melanocortin peptide. They differ in mechanism, dosing, and clinical evidence. Your choice should depend on your specific goals and medical history.
Switching should be done under medical supervision. Your prescriber can advise on transition protocols. Track both in Shotlee for comparison data.
PT-141 (Bremelanotide) works as a melanocortin receptor agonist (1.75 mg SC as needed (max 1 dose/24h, 8 doses/month)), while Melanotan II is a synthetic melanocortin peptide (0.5-1 mg SC daily (loading) then weekly (anecdotal)). They have different half-lives (~2.7 hours vs ~2 hours), side effect profiles, and levels of clinical evidence.
Yes. Shotlee supports tracking any medication or peptide. You can compare your results across different protocols.
Neither is universally better — the right choice depends on your individual health profile, treatment goals, side effect tolerance, insurance coverage, and prescriber recommendation. Clinical trial data shows efficacy differences in specific populations, but personal response varies. Track your experience with either medication in Shotlee to generate objective comparison data with your healthcare provider.
Switching between these medications should be done under medical supervision. Your prescriber will consider factors including your current response, reason for switching, dose equivalence, and transition timing. Use Shotlee to document your outcomes on the current medication so you have a clear baseline for comparison after switching.
References
- [1]Clinical TrialKingsberg SA et al. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder (RECONNECT). Obstet Gynecol. 2019;134(5):899-908.
- [2]Clinical TrialDorr RT et al. Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996;58(20):1777-1784.
- [3]FDAAMAG Pharmaceuticals. Vyleesi (bremelanotide) Prescribing Information. U.S. FDA.
Track Pt 141 or Melanotan in Shotlee
Free dose tracking, side effect logging, and outcome comparison for any medication protocol.
🚀 Use Shotlee for Free